sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Russia In Vitro Fertilization (IVF) Market by End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes), Cycle Type (Fresh IVF Cycles (Non-donor), Thawed IVF Cycles (Non-donor), and Donor Egg IVF Cycles), Type (Non-intracytoplasmic Sperm Injection (ICSI) IVF Cycles, and ICSI-Assisted IVF Cycles), Drug (Clomiphene Citrate, Aromatase Inhibitors, Gonadotropins & Gonadotropin-releasing Hormone, Follicle-stimulating Hormone, Progesterone, and Others), and Mode of Administration (Oral, Injectable, and Vaginal) - Opportunity Analysis and Industry Forecast, 2014-2022

Russia In Vitro Fertilization (IVF) Market by End User (Fertility...

Home / Categories / Healthcare
Russia In Vitro Fertilization (IVF) Market by End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes), Cycle Type (Fresh IVF Cycles (Non-donor), Thawed IVF Cycles (Non-donor), and Donor Egg IVF Cycles), Type (Non-intracytoplasmic Sperm Injection (ICSI) IVF Cycles, and ICSI-Assisted IVF Cycles), Drug (Clomiphene Citrate, Aromatase Inhibitors, Gonadotropins & Gonadotropin-releasing Hormone, Follicle-stimulating Hormone, Progesterone, and Others), and Mode of Administration (Oral, Injectable, and Vaginal) - Opportunity Analysis and Industry Forecast, 2014-2022
Russia In Vitro Fertilization (IVF)...
Report Code
RO1/113/1217

Publish Date
01/Jul/2017

Pages
77
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1 RUSSIA IVF MARKET

1.1. EUROPE IVF MARKET (REVENUE AND NUMBER OF CYCLES)
1.2. RUSSIA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

1.2.1. Market size and forecast
1.2.2. Russia IVF market, by end user

1.2.2.1. Market size and forecast
1.2.2.2. Fertility clinics
1.2.2.3. Hospitals
1.2.2.4. Surgical centers
1.2.2.5. Clinical research institutes

1.2.3. Russia IVF market, by cycle type

1.2.3.1. Market size and forecast
1.2.3.2. Fresh IVF cycles (non-donor)
1.2.3.3. Thawed IVF cycles (non-donor)
1.2.3.4. Donor egg IVF cycles

1.2.4. Russia IVF market, by type

1.2.4.1. Market size and forecast
1.2.4.2. Non-ICSI IVF cycles
1.2.4.3. ICSI-assisted IVF cycles

1.2.5. Russia IVF market by pharmacological modality

1.2.5.1. Overview
1.2.5.2. Key trends
1.2.5.3. Market size and forecast
1.2.5.4. Duration of therapy
1.2.5.5. Segmentation of drugs for IVF

1.2.5.5.1. Clomiphene citrate
1.2.5.5.2. Aromatase inhibitors
1.2.5.5.3. Gonadotropins & gonadotropin-releasing hormone (GnRH)
1.2.5.5.4. Follicle-stimulating hormone (FSH)
1.2.5.5.5. Progesterone
1.2.5.5.6. Others

1.2.5.6. Mode of administration

1.2.5.6.1. Oral
1.2.5.6.2. Injectable
1.2.5.6.3. Vaginal

1.2.6. Market dynamics

1.2.6.1. Drivers

1.2.6.1.1. Rise in popularity of fertility tourism
1.2.6.1.2. Advanced IVF facilities and treatment options

1.2.6.2. Restraint

1.2.6.2.1. Inadequate reimbursement policies

1.2.7. Regulatory issues, legislations, and authorities
1.2.8. Insurance reimbursement scenario

CHAPTER 2 COMPANY PROFILES

2.1. AVA-PETER CLINIC

2.1.1. Company overview
2.1.2. Company snapshot
2.1.3. Product portfolio

2.2. MD MEDICAL GROUP INVESTMENTS PLC (MD MEDICAL GROUP)

2.2.1. Company overview
2.2.2. Company snapshot
2.2.3. Operating business segments
2.2.4. Product portfolio
2.2.5. Business performance
2.2.6. Key strategic moves and developments

2.3. IVF RUSSIA (THE INTERNATIONAL CENTRE OF THE REPRODUCTIVE MEDICINES)

2.3.1. Company overview
2.3.2. Company snapshot
2.3.3. Operating business segments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com